Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N6O4 |
InChIKeyAGUUKKXWABRVBZ-UHFFFAOYSA-N |
CAS Registry851941-94-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 29 Jan 2015 |